← back to search

Kim Vettenranta

Lassila & Tikanoja (Finland) · FI
Area of research
Public Health, Environmental and Occupational Health · Hematology
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Hematopoietic Stem Cell Transplantation, and Neuroblastoma Research and Treatments.
h-index
44
citations
6,254
works
277
NIH funding
primary concept
Medicine
email

Recent publications

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.
2026cited by 0position: contributordoi
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM.
2025cited by 2position: contributordoi
FASCIA Method in the Assessment of Lymphocyte Mitogen Responses in the Laboratory Diagnostics of Primary Immunodeficiencies.
2023cited by 2position: contributordoi
Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?
Frontiers in Pediatrics 2022cited by 29position: middledoi
Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physicians
Bone Marrow Transplantation 2022cited by 2position: middledoi
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort
Journal of Allergy and Clinical Immunology 2021cited by 107position: middledoi
RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosis.
2021cited by 41position: contributordoi
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
Bone Marrow Transplantation 2021cited by 1position: middledoi
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
Journal of Clinical Oncology 2020cited by 320position: middledoi
Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia
Blood 2020cited by 67position: middledoi
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
Bone Marrow Transplantation 2020cited by 60position: middledoi
ABO incompatibile graft management in pediatric transplantation
Bone Marrow Transplantation 2020cited by 6position: middledoi
Correction: ABO incompatibile graft management in pediatric transplantation
Bone Marrow Transplantation 2020cited by 0position: middledoi
Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia
Leukemia 2017cited by 414position: middledoi
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group
Bone Marrow Transplantation 2017cited by 64position: middledoi
State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29–30 September 2015
Bone Marrow Transplantation 2017cited by 54position: middledoi
Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning
British Journal of Haematology 2015cited by 77position: middledoi
Toxicity profile and treatment delays in <scp>NOPHO ALL</scp>2008—comparing adults and children with Philadelphia chromosome‐negative acute lymphoblastic leukemia
European Journal Of Haematology 2015cited by 77position: middledoi
Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol
European Journal Of Haematology 2013cited by 138position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2013–2020) · 4 papers (2021–2026)Mats Heyman · Karolinska University Hospital4 papers (2013–2020)Jonas Abrahamsson · Lund University4 papers (2013–2020)Kjeld Schmiegelow · University of Copenhagen4 papers (2013–2020) · 3 papers (2013–2017) · 3 papers (2013–2017) · 3 papers (2013–2017) · 3 papers (2015–2020)Christina Peters · Nottingham City Hospital3 papers (2020–2025)Tobias Wirenfeldt Klausen · Copenhagen University Hospital3 papers (2013–2017)Jochen Buechner · Université de Montréal3 papers (2020–2025)Laimonas Griškevičius · The University of Texas Health Science Center at Houston3 papers (2013–2017) · 3 papers (2013–2020) · 2 papers (2013–2015) · 2 papers (2013–2015) · 2 papers (2013–2015) · 2 papers (2015–2017)Peter Bader · Children's Clinical University Hospital2 papers (2020–2022) · 2 papers (2015–2020)